English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Boehringer-Ingelheim
Carol Ostrow
| Dec 15, 2017
Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui
| Jun 14, 2017
Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson
| Feb 25, 2017
Combination therapy targets lung cancer
Carol Ostrow
| Feb 19, 2017
Partnership spurs efforts against COPD
Amanda Rupp
| Jun 28, 2016
Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp
| Jun 5, 2016
Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp
| May 31, 2016
Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp
| May 25, 2016
BioMed X, Boehringer Ingelheim partner for psychiatric treatments
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'
1
2
»
Last »